25 May 2013
Keywords: genetics, institute, neumega, backed, fda, panel, marketletter
Article | 30 July 1997
As the Marketletter predicted in a report last week (July 28), the USFood and Drug Administration Biological Response Modifiers Advisory Committee ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.